205 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
and hedging transactions Prohibition on pledging shares and holding them in a margin account Proactively eliminate windfall gain potential No employment … engaging in any speculative or hedging transactions, as we consider it improper and inappropriate to engage in any transactions that hedge or offset
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
, financial advisory, investment management, principal investment, hedging, financing and brokerage activities. For example, certain of the underwriters … as counterparties to certain derivative and hedging arrangements, and actively trade debt and equity securities (or related derivative securities
424B2
an0nnzmg1x cbxpjd
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
16apahe qh7
25 Jan 24
Third party tender offer statement
8:13am
424B5
3mgp0k9l99 b8odr1x
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
n455cab0vd ico
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
z9f5xy63gy86r62ghvf
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
rwad tabymqd4g
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
oobei5nry
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
nrvvp36
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
67nuop7lmq1qj4
17 Jun 22
Third party tender offer statement
4:42pm